Abstract
The number of young cancer survivors is increasing owing to advances in cancer therapeutics, but many face infertility as a result of their treatment. Technologies that already exist for cancer patients concerned about their future fertility include sperm banking for men and hormonal intervention followed by in vitro fertilization and embryo cryopreservation for women. However, logistical barriers to timely patient referral and coordination of care between specialties can limit patient access to all the available options. Moreover, there are few alternatives for young women and girls who cannot delay their cancer treatment, or who are unable to undergo hormonal intervention. The Oncofertility Consortium is a network of researchers, physicians and scholars who are advancing fertility preservation options for young cancer patients. Research into the societal, ethical, and legal implications is also an important part of the work performed by the Oncofertility Consortium, which is providing new perspectives on patient decision-making about how to access these emerging reproductive technologies. Experts in the fields of oncology, reproductive medicine, the social sciences, law, education, and the humanities are working together to develop next-generation reproductive interventions and promote communication between scholars, clinicians, patients, and the public to ensure that young cancer patients are equipped with the most appropriate information and options for having a family in the future.
Key Points
-
Advances in cancer diagnostics and therapeutics have increased the number of young cancer survivors; however, some life-preserving cancer treatments can pose a threat to a patient's fertility
-
The Oncofertility Consortium is a confederation of partners funded by an NIH Roadmap grant that is advancing fertility preservation options for young cancer patients
-
The NIH Roadmap Grant program provides a unique structure that supports the work of multidisciplinary teams to solve large, intractable problems in health care
-
The development of a National Physicians Cooperative brings together the specialties of oncology and reproductive medicine to more-efficiently guide patients after a cancer diagnosis
-
Collaborations between biomaterials scientists, reproductive endocrinologists, and clinical researchers have led to breakthroughs that may improve and expand fertility preservation options for women
-
Cooperation with the social sciences, humanities, law, and education allows a comprehensive means of understanding and fulfilling the needs of patients wishing to preserve fertility after a cancer diagnosis
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Jemal, A. et al. Cancer statistics, 2009. CA Cancer J. Clin. 59, 225–249 (2009).
Jeruss, J. S. & Woodruff, T. K. Preservation of fertility in patients with cancer. N. Engl. J. Med. 360, 902–911 (2009).
Quinn, G. P. et al. Discussion of fertility preservation with newly diagnosed patients: oncologists views. J. Cancer Surviv. 1, 146–155 (2007).
Agarwal, S. K. & Chang, R. J. Fertility management for women with cancer. Cancer Treat. Res. 138, 15–27 (2007).
Snyder, K. A. Oncofertility and the social sciences. Cancer Treat. Res. 138, 137–148 (2007).
Dolin, G., Roberts, D., Rodriguez, L. & Woodruff, T. Medical hope, legal pitfalls: potential legal issues in the emerging field of oncofertility. Santa Clara Law Rev. 49, 673–716 (2009).
Backhus, L. E. & Zoloth, L. Today's research, tomorrows cures: the ethical implications of oncofertlity. Cancer Treat. Res. 138, 163–179 (2007).
Pauli, S. A., Berga, S. L., Shang, W. & Session, D. R. Current status of the approach to assisted reproduction. Pediatr. Clin. North Am. 56, 467–488 (2009).
Kelly, S. M., Buckett, W. M., Abdul-Jalil, A. K. & Tan, S. L. The cryobiology of assisted reproduction. Minerva Ginecol. 55, 389–398 (2003).
Chian, R. C. et al. Obstetric and perinatal outcome in 200 infants conceived from vitrified oocytes. Reprod. Biomed. Online 16, 608–610 (2008).
Noyes, N., Porcu, E. & Borini, A. Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies. Reprod. Biomed. Online 18, 769–776 (2009).
Chian, R. C. et al. Obstetric outcomes following vitrification of in vitro and in vivo matured oocytes. Fertil. Steril. 91, 2391–2398 (2009).
Antinori, M. et al. Cryotop vitrification of human oocytes results in high survival rate and healthy deliveries. Reprod. Biomed. Online 14, 72–79 (2007).
Cobo, A. et al. Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method. Fertil. Steril. 89, 1657–1664 (2008).
Society for Assisted Reproductive Technology; American Society for Reproductive Medicine. Assisted reproductive technology in the United States: 2000 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Fertil. Steril. 81, 1207–1220 (2004).
Gunby, J., Bissonnette, F., Librach, C. & Cowan, L. IVF Directors Group of the Canadian Fertility and Andrology Society. Assisted reproductive technologies in Canada: 2005 results from the Canadian Assisted Reproductive Technologies Register. Fertil. Steril. 91, 1721–1730 (2009).
Castilla, J. A. et al. Assisted reproductive technologies in public and private clinics. Reprod. Biomed. Online 19, 872–878 (2009).
Yli-Kuha, A. N., Gissler, M., Luoto, R. & Hemminki, E. Success of infertility treatments in Finland in the period 1992–2005. Eur. J. Obstet. Gynecol. Reprod. Biol. 144, 54–58 (2009).
Marks, A. R. Rescuing the NIH before it is too late. J. Clin. Invest. 116, 844 (2006).
Crowley, W. et al. The Clinical Research Forum and Association of American Physicians disagree with criticism of the NIH Roadmap. J. Clin. Invest. 116, 2058–2059 (2006).
National Institutes of Health. The NIH Common Fund: About the NIH Roadmap [online], (2009).
DelVecchio, R. Panel looks at control of emissions. San Francisco Chronicle (22 Mar 2007).
Woodruff, T. K. The emergence of a new interdiscipline: oncofertility. Cancer Treat. Res. 138, 3–11 (2007).
Klock, S. C., Zhang, J. X. & Kazer, R. R. Fertility preservation of female cancer patients: early clinical experience. Fertil. Steril. doi: 10.1016/j.fertnstert.2009.03.028.
West, E. R. et al. Preserving female fertility following cancer treatment: current options and future possibilities. Pediatr. Blood Cancer 53, 289–295 (2009).
Clayman, M. L., Galvin, K. M. & Arntson, P. Shared decision making: fertility and pediatric cancers. Cancer Treat. Res. 138, 149–160 (2007).
Lee, S. J. et al. American Society of Clinical Oncoloy recommendations on fertility preservation in cancer patients. J. Clin. Oncol. 24, 2917–2931 (2006).
Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertil. Steril. 83, 1622–1628 (2005).
Agarwal, R. Semen banking in patients with cancer: 20-year-experience. Int. J. Androl. 23 (Suppl. 2), 16–19 (2000).
Schover, L. R., Agarwal, A. & Thomas, A. J. Jr. Cryopreservation of gametes in young patients with cancer. J. Pediatr. Hematol. Oncol. 20, 426–428 (1998).
Kohler, T. S. et al. Gender disparity in delivery of fertility preservation message to adolescents with cancer. Cancer (in press).
Fertile Hope. Sperm banking—Sharing Hope program for men [online], (2009).
Schlatt, S., Ehmcke, J. & Jahnukainen, K. Testicular stem cells for fertility preservation: preclinical studies on male germ cell transplantation and testicular grafting. Pediatr. Blood Cancer 53, 274–280 (2009).
Nayernia, K. et al. RETRACTION—In vivo derivation of human sperm from embryonic stem cells. Stem Cells Dev. doi: 10.1089/scd.2009.0063.
Oktay, K. et al. Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum. Reprod. 18, 90–95 (2003).
Oktay, K., Buyuk, E., Libertella, N., Akar, M. & Rosenwaks, Z. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J. Clin. Oncol. 23, 4347–4353 (2005).
Huang, J. Y. J., Buckett, W. M., Gilbert, L., Tan, S. L. & Chian, R. C. Retrieval of immature oocytes followed by in vitro maturation and vitrification: a case report on a new strategy of fertility preservation in women with borderline ovarian malignancy. Gynecol. Oncol. 105, 542–544 (2007).
Rao, G. D., Chian, R. C., Son, W. S., Gilbert, L. & Tan, S. L. Fertility preservation in women undergoing cancer treatment. Lancet 363, 1829–1830 (2004).
Gosden, R. G. Prospects for oocyte banking and in vitro maturation. J. Natl Cancer Inst. Monogr. 34, 60–63 (2005).
Gosden, R. Gonadal tissue cryopreservation and transplantation. Reprod. Biomed. Online 4 (Suppl. 1), 64–67 (2002).
Demeestere, I., Simon, P., Emiliani, S., Delbaere, A. & Englert, Y. Fertility preservation: successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin's disease. Oncologist 12, 1437–1442 (2007).
Donnez, J. et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 364, 1405–1410 (2004).
Meirow, D. et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N. Engl. J. Med. 353, 318–321 (2005).
Silber, S. J. et al. A series of monozygotic twins discordant for ovarian failure: ovary transplantation (cortical versus microvascular) and cryopreservation. Hum. Reprod. 23, 1531–1537 (2008).
Silber, S. J. & Gosden, R. G. Ovarian transplantation in a series of monozygotic twins discordant for ovarian failure. N. Engl. J. Med. 356, 1382–1384 (2007).
Silber, S. J. et al. Ovarian transplantation between monozygotic twins discordant for premature ovarian failure. N. Engl. J. Med. 353, 58–63 (2005).
Silber, S. J., Grudzinskas, G. & Gosden, R. G. Successful pregnancy after microsurgical transplantation of an intact ovary. N. Engl. J. Med. 359, 2617–2618 (2008).
Andersen, Y. et al. Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue. Hum. Reprod. 23, 2266–2272 (2008).
Cortvrindt, R., Smitz, J. & Van Steirteghem, A. C. In vitro maturation, fertilization and embryo development of immature oocytes from early preantral follicles from prepubertal mice in a simplified culture system. Hum. Reprod. 11, 2656–2666 (1996).
Eppig, J. J. & O'Brien, M. J. Development in vitro of mice oocytes from primordial follicles. Biol. Reprod. 54, 197–207 (1996).
O'Brien, M. J., Pendola, J. K. & Eppig, J. J. A revised protocol for in vitro development of mouse oocytes from primordial follicles dramatically improves their developmental competence. Biol. Reprod. 68, 1682–1686 (2003).
Pangas, S. A., Saudye, H., Shea, L. D. & Woodruff, T. K. Novel approach for the three-dimensional culture of granulosa cell-oocyte complexes. Tissue Eng. 9, 1013–1021 (2003).
Spears, N., Boland, N. I., Murray, A. A. & Gosden, R. G. Mouse oocytes derived from in vitro grown primary ovarian follicles are fertile. Hum. Reprod. 9, 527–532 (1994).
Telfer, E. E., McLaughlin, M., Ding, C. & Thong, K. J. A two-step serum-free culture system supports development of human oocytes from primordial follicles in the presence of activin. Hum. Reprod. 23, 1151–1158 (2008).
Xu, M. et al. In vitro grown human ovarian follicles from cancer patients support oocyte growth. Hum. Reprod. 24, 2531–2540 (2009).
Xu, M., Kreeger, P. K., Shea, L. D. & Woodruff, T. K. Tissue-engineered follicles provide live, fertile offspring. Tissue Eng. 12, 2739–2746 (2006).
Xu, M. et al. Encapsulated three-dimensional culture supports development of nonhuman primate secondary follicles. Biol. Reprod. 81, 587–594 (2009).
Huang, J. Y. J., Tulandi, T., Holzer, H., Tan, S. L. & Chian, R. C. Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation. Fertil. Steril. 89, 567–572 (2008).
Oktay, K. et al. Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet 363, 837–840 (2004).
Silber, S., Kagawa, N., Kuwayama, M. & Gosden, R. Duration of fertility after fresh and frozen ovary transplantation. Fertil. Steril. doi: 10.1016/j.fertnstert.2009.12.073.
Amorim, C. A., Van Langendonckt, A., David, A., Dolmans, M. M. & Donnez, J. Survival of human pre-antral follicles after cryopreservation of ovarian tissue, follicular isolation and in vitro culture in a calcium alginate matrix. Hum. Reprod. 24, 92–99 (2009).
Azim, A. A., Costantini-Ferrando, M. & Oktay, K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J. Clin. Oncol. 26, 2630–2635 (2008).
Miller, J. D., Pardo, R. & Niwa, F. Public Perceptions of Science and Technology: a Comparative Study of the European Union, the United States, Japan, and Canada (BBV Foundation Press, Madrid, 1997).
MyOncofertility.org. A patient education resource provided by the Oncofertility Consortium [online], (2009).
Woodruff, T. K., Campo-Engelstein, L., Rodriguez, S. & Zoloth, L. (Eds) Oncofertility: Perspectives from the Humanities and Social Sciences (Springer, New York, 2010).
Zoloth, L., Backhus, L. & Woodruff, T. K. Waiting to be born: the ethical implications of the generation “NUBorn” and “NUAge” mice from pre-pubertal ovarian tissue. Am. J. Bioeth. 8, 21–29 (2008).
Campo-Engelstein, L. Consistency in insurance coverage for iatrogenic conditions resulting from cancer treatment including fertility preservation. J. Clin. Oncol. 28, 1284–1286 (2010).
Acknowledgements
The Oncofertility Consortium is funded by a number of NIH Interdisciplinary Research Consortium grants: NIDCR 8UL1DE019587, NICHD 1RL1HD058293, NICHD 1RL1HD058294, NICHD 5RL1HD058295, NICHD 5RL1HD058296, NIBIB 5PL1EB008542, NCI 1PL1CA133835, NCI 5RL5CA133836, NCI 5TL1CA133837/5RL9CA133838, NCI 1KL1CA133839. The original in vitro follicle maturation studies were funded by a Specialized Cooperative Centers Program in Infertility Research (SCCPIR) NIH/NICHD U54HD041857. The author is grateful for the comments of an interdisciplinary team of readers (listed alphabetically: Lisa Campo-Engelstein, Marla Clayman, Francesca Duncan, Shauna Gardino, Marybeth Gerrity, Sarah Rodriguez, Lonnie Shea, Candace Tingen and Min Xu). The author also thanks Stacey Tobin for assistance with language editing.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Woodruff, T. The Oncofertility Consortium—addressing fertility in young people with cancer. Nat Rev Clin Oncol 7, 466–475 (2010). https://doi.org/10.1038/nrclinonc.2010.81
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrclinonc.2010.81
This article is cited by
-
Thyroid hormone triiodothyronine does not protect ovarian reserve from DNA damage induced by X-ray and cisplatin
Journal of Assisted Reproduction and Genetics (2023)
-
Evaluating fertility preservation interventions for alignment with ASCO Guidelines for reproductive aged women undergoing cancer treatment: a systematic review
Supportive Care in Cancer (2023)
-
Human ovarian tissue in-vitro culture: primordial follicle activation as a new strategy for female fertility preservation
Cytotechnology (2022)
-
A synopsis of global frontiers in fertility preservation
Journal of Assisted Reproduction and Genetics (2022)
-
Human adipose-derived stromal cells transplantation prolongs reproductive lifespan on mouse models of mild and severe premature ovarian insufficiency
Stem Cell Research & Therapy (2021)